A Double-Blind, Randomised, Placebo-controlled, Parallel Group, International, Multi-centre Phase 2 Trial Investigating the Safety and Efficacy of CRD007 in Adult Subjects With Asthma
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Pemirolast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors RSPR Pharma
- 24 May 2017 Results assessing short term variability in FEV1, reversibility and ACQ6 during the run-in period, presented at the 113th International Conference of the American Thoracic Society
- 24 Feb 2017 Status changed from active, no longer recruiting to completed.
- 15 Nov 2016 Status changed from recruiting to active, no longer recruiting.